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Abstract
Background: Developments in chemotherapy have led to changes in cancer care in Japan, with the government
promoting a transition to outpatient chemotherapy. This requires patients and their families to participate more
actively in treatment than in the past. However, it remains unclear how patients’ motivation for medical treatment
affects clinical consultations with their physicians. To investigate this, we developed a psychological index called the
Achievement Motive Index for Medical Treatment (AMI-MeT), which comprises self-derived achievement motivation
(AMS) and achievement motivation derived from others (AMO). However, its factor structure has not yet been
confirmed in populations other than healthy university students. Thus, the aims of this study were to confirm the factor
structure of the AMI-MeT in other groups and to determine the convergent and divergent validity of the AMI-MeT.
Methods: The AMI-MeT was administered to university students (n = 414), apparently healthy workers (n = 154), and
cancer patients (n = 51). Multi-group confirmatory factor analysis was conducted and the mean scores of the AMI-MeT
were compared between the groups. Correlations between the AMI-MeT and the Self-Construal Scale, comprising
independent self-construal (IndSC) and interdependent self-construal (InterSC) subscales, were investigated in another
group of students (n = 335).
Results: The multi-group confirmatory factor analysis supported a two-factor structure of the AMI-MeT: the weak
invariance model was the best fit for the data. The mean scores of the AMI-MeT in apparently healthy workers and
cancer patients were significantly higher than that in students (P < .01). The correlation analysis revealed that AMS
scores were associated with IndSC scores (r = .25, P < .01) and AMO scores with InterSC scores (r = .30, P < .01).
Conclusion: The two-factor model of the AMI-MeT was deemed appropriate for all three groups, and the subscales of
the AMI-MeT successfully reflected the self and other dimensions. The AMI-MeT appears to be an effective tool for
measuring medical treatment motivation, making it useful in participant observational research on medical
consultations for Japanese cancer treatment.
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Background
Japan has a history of withholding cancer notification
[1], but many surveys have indicated a gradual shift to-
wards disclosing such information [2–7]. Furthermore,
developments in chemotherapy have led to changes in
cancer care in Japan, and the government has promoted
a transition towards outpatient chemotherapy since 2007
[8]. Cancer patients and their families have acknowl-
edged the benefits of outpatient chemotherapy; however,
it also requires them to participate more actively in
treatment than in the past. Despite much research on
Japanese cancer patients’ preferences for receiving bad
news [9–11], it remains unclear how patients’ motivation
to obtain medical treatment affects clinical consultations
with their physicians. To investigate this, we launched the
Mixed-methods Observational Research for Informed
Consent (MORE-IC) project [12, 13], wherein we per-
formed quantitative and qualitative participant observa-
tion of informed consent consultations involving cancer
patients. However, this project demanded the availability
of a convenient/easily answerable questionnaire for quan-
tifying patients’ interest in medical treatment before start-
ing their consultations. As no such tool exists, we
developed a psychological index of patient motivation for
treatment, called the Achievement Motive Index for
Medical Treatment (AMI-MeT).
Although many patients have been inclined to actively
participate in treatment decision making in Japan [2],
those who actually can clearly convey their intentions to
their physicians remain a relative minority. Physician–
patient communication, and the intention underlying
patients’ communication about their medical treatment,
relates to several factors, such as the social values of the
hospital, expectations for medical treatment, preferences
for communication style, and so on. Notably, these fac-
tors can be interpreted according to the theory of
planned behavior [14], as they correspond to the con-
cepts of attitude toward the behavior, subjective norms,
and perceived behavior control, which all influence
intention. Given that few patients can clearly convey
their intentions, we thought it necessary to include the
potential interest behind the intention for medical treat-
ment in the concept of motivation for medical treat-
ment. On the other hand, the dualistic concept of
achievement motivation in the AMI-MeT was derived
from the concepts of self-fulfillment and competition
achievement [15], which are analogous to the concepts
of self-achievement [16] and ordinal achievement motiv-
ation [17, 18], respectively. According to literature on
patients’ narratives [19–21], patients often seek to re-
main themselves during long-term treatment and to cre-
ate a new identity or continuity of self at the end of life;
thus, we supposed that the process of medical decision
making can be construed as a form of self-actualization
[16] or individuation [22]. To understand how patients
view medical treatment, we also referred to the other
dualistic concepts of the self and motivation: construals
of the self as independent/interdependent [23], and in-
trinsic/extrinsic motivation [24]. Using these concepts,
we holistically defined achievement motivation for med-
ical treatment as a personal interest and value that could
exert a potent influence on medical decision making and
would be influenced by social norms or expectations.
In an earlier study, we conducted an exploratory factor
analysis to derive the subscales of the AMI-MeT, which
were as follows: self-derived achievement motivation
(AMS), containing 5 items (e.g., “I want to make the best
decision for me,” “Even if several therapies are available,
I want to find the one that’s preferable for me”); and
achievement motivation derived from others (AMO),
also containing 5 items (e.g., “It’s important to strive for
advanced medical care,” “I want to be treated at a noted
hospital”) (Table 1) [25]. The scale items are rated on a
7-point Likert-type scale ranging from 1 (strongly dis-
agree) to 7 (strongly agree). In the previous pilot study,
these two subscales had adequate reliability (Cronbach’s
alpha = .78–.86), and the construct validity of the AMI-
MeT was confirmed through a comparison with Horino’s
achievement motive scale [15]. The items of the AMI-
MeT were developed in Japanese and translated into
English for the present paper (Table 1). As shown in
Table 1, the items do not directly represent motivation
itself, but indicate a personal interest and value for med-
ical treatment, because of the broad definition of motiv-
ation used in this study.
However, because the AMI-MeT was preliminarily de-
veloped in a rather small sample of university students,
its reliability and validity remain insufficient. Specifically,
the AMI-MeT was tested only using exploratory factor
analysis in a single sample of university students; no
confirmatory factor analysis has been performed in other
Table 1 A list of items on the Achievement Motive Index for
Medical Treatment
Sentence of each items
Achievement Motivation Derived from Other (AMO)
Q1: It’s important to strive for advanced medical care.
Q2: I want to be treated at a noted hospital.
Q3: Selecting a therapy grounded in medicine is important.
Q4: I’d be happy to receive better-than-average care.
Q5 If treatment works well, that means living longer.
Self-derived Achievement Motivation (AMS)
Q6: I want to make the best decision for me.
Q7: I should be convinced with various things that matter.
Q8: It’s important for me to follow my heart rather than to trouble
myself with the ideas of others.
Q9: Even if several therapies are available, I want to find the one
that’s preferable for me.
Q10: I want to express my wishes, even if it’s something that’s not
very significant.
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populations. Additionally, the AMI-MeT has not yet been
applied to the patient population—so far, it can only assess
the motivation of university students, who do not have the
same needs or interests as do patients. Finally, it remains
unclear whether the subscales (AMS and AMO) are in
fact based on dualistic concepts of the self, since they have
been found to correlate only with achievement for self-
fulfillment/competition [15]. These issues indicated the
necessity for further investigation of the AMI-MeT among
university students as well as other populations.
The aims of this article are, in two studies, to demon-
strate that the AMI-MeT data from university students,
apparently healthy workers, and cancer patients fit the
two-factor model; that AMI-MeT scores differ between
the three groups; and that the AMI-MeT subscales cor-
relate with dualistic concepts of the self.
Methods
Ethical considerations
The questionnaire surveys were approved by the institu-
tional review board at Kyoto University Graduate School
of Medicine (E-570, E-1107, E-1254, E-1387, and E 1426)
and the Kyoto Industrial Health Association (April 2011).
Study 1: investigating the factor structure and the mean
scores of the AMI-MeT in multiple groups
To confirm the factor structure of the AMI-MeT in more
diverse groups and demonstrate that it accurately assesses
motivation for medical treatment, we administered the
AMI-MeT to several groups with varying needs for medical
treatment: university students, apparently healthy workers,
and cancer patients. It is likely that most university stu-
dents, a young and comparatively healthy population, are
less likely to need medicine or to go to the hospital, making
them generally less motivated to do. In contrast, cancer pa-
tients who have already been diagnosed and informed of
their diagnosis might feel a greater need for medical treat-
ment—therefore, they are perhaps a relatively highly moti-
vated population. Workers who had come to a medical
institution for a health check were proposed to be a mid-
dle population in terms of motivation, somewhere be-
tween university students and cancer patients, as they
would be potentially aware of the concerns or needs for
medical treatment, but not to the same extent as would
cancer patients. In other words, given that this group had
voluntarily gone for a health screening, they were likely
concerned about having undiagnosed diseases or perhaps
realized the necessity of obtaining treatment. As such, we
defined them as an “apparently healthy” group.
Participants and measure
The first group comprised university students from the
Kansai region of Japan, who were asked to complete the
questionnaire after a psychology class between October
and November 2011. Of the 456 students given the
questionnaire, 414 responded to all items of the
questionnaire (317 women and 97 men; mean age = 20.8;
SD = 5.4); we excluded any answer sheets that contained
missing data. The second group comprised apparently
healthy workers—that is, workers who had not yet been
diagnosed with a disease but who had voluntarily under-
gone a health screening at a medical institution of the
Kyoto Industrial Health Association between April 2011
and March 2012. Two hundred and thirty-three workers
received the questionnaire after their health checks at the
institution, and 164 completed it; of these, 154 valid re-
sponses were obtained (51 women and 103 men; mean
age = 46.3; SD = 12.4). The third group comprised patients
who had been diagnosed with breast or lung cancer and
had come to start chemotherapy at Kyoto University Hos-
pital between January and July 2009 or between April
2012 and January 2013. The questionnaire survey was ad-
ministered to cancer patients who were part of the
MORE-IC project. After the first author explained the aim
of the MORE-IC project, 51 valid responses were obtained
(32 women and 19 men; mean age = 60.8; SD = 11.6).
Motivation for medical treatment was measured using
the AMI-MeT, as described previously.
Analysis 1: multi-group structural equation modeling
To confirm the factor structure of the AMI-MeT in all
three groups, we performed a confirmatory factor ana-
lysis with maximum likelihood estimation. Specifically,
we used structural equation modeling (SEM) with a
multi-group procedure [26–28] and compared the model
invariance: configural, weak, strong, and complete in-
variance. Configural invariance is the simplest form of
invariance, wherein no constraints are placed on the pa-
rameters; it is satisfied if a defined factor structure is a
good fit to the data for all groups. Then, weak, strong,
and complete forms of invariance were tested in se-
quence by placing constraints on the parameters (i.e.,
factor loadings, factor variances/covariance, and error
variances) of the configural invariance model [27, 28].
Specifically, testing weak invariance involves constrain-
ing the factor loadings to be equal between the groups;
when weak invariance is satisfied (i.e., the model is a
good fit), the latent variables being measured are the
same across the groups. Testing strong invariance in-
volves placing equality constraints on both the factor
loadings and the factor variances/covariance between
groups; if it is satisfied, group comparisons of the do-
main means can be performed. Complete invariance
holds if the factor loadings, factor variances/covariance,
and error variances are equivalent for the groups [28].
To evaluate and compare these models, the chi-squared
model test (χ2/df) and chi-square difference test (Δχ2) [29]
were conducted. To test model fit, we used the following
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fit indices: the goodness of fit index (GFI), the adjusted
goodness of fit index (AGFI), the comparative fit index
(CFI), the Akaike information criterion (AIC), and the
root mean square error of approximation (RMSEA). The
GFI, AGFI, and CFI range between zero (0) and unity (1),
with unity meaning a perfect fit to the data. The AIC ad-
justs for model complexity [30], and smaller values indi-
cate better fit [31]. An RMSEA of about 0.05 or less
indicates a close fit of the model in relation to the degrees
of freedom, while about 0.08 or less indicates a reasonable
error of approximation. However, such cut-offs should be
regarded as guidelines rather than as “golden rules” when
assessing model fit [32]. The confirmatory factor ana-
lysis was performed with AMOS 22.0. The chi-square
difference test [29] and the internal consistency reli-
ability coefficient McDonald’s ω [33–36] were calcu-
lated with Microsoft Excel.
Analysis 2: one-way analysis of variance of AMI-MeT scores
between the three groups
To demonstrate whether the AMI-MeT score (ten items)
of cancer patients and workers are higher than are those
of students, we performed a one-way analysis of variance
(ANOVA with post hoc pairwise Bonferroni-adjusted
comparisons) between the three groups. The statistical
analysis was performed with SPSS 22.0. The effect size
(η2) was also calculated with Microsoft Excel.
Study 2: correlating the subscales of the AMI-MeT with
the dualistic concept of the self
To determine the convergent and divergent validity of
the AMI-MeT, we examined whether it correlates with
another theoretically relevant psychological scale. In this
case, we referred to the concept of self-construal [23],
which is typically defined as how individuals see the self
in relation to others [37]. Markus and Kitayama coined
the term “self-construal” in describing differences in the
ways that Americans and Japanese define and make mean-
ing of the self; they identified two types of self-construal:
independent and interdependent [23]. Cross et al. re-
viewed the two types of self-construals, as follows:
Markus and Kitayama (1991) proposed that
Europeans and Americans construe the self as
fundamentally individual and separate from others,
and they labeled this the independent self-construal
(IndSC)…. In contrast, Markus and Kitayama (1991)
pointed out that the Japanese tend to construe the self
as fundamentally connected to others and defined by
relationships with others, which they labeled the
interdependent self-construal (InterSC). ([37] p. 143)
In later works, InterSC was proposed to consist of two
components: “relational component” and “group-oriented
component” [37–39]. Although Markus and Kitayama
(1991) defined InterSC in terms of close relationships and
important in-groups, “the connection between IndSC and
individualism and between InterSC and collectivism is
clear—so clear, in fact, that it can be difficult to distinguish
between self-construal and individualism–collectivism”
([37] p. 143).
Given this conceptual background, we assumed that
AMS (which includes items such as “I want to make the
best decision for me” and “Even if several therapies are
available, I want to find the one that’s preferable for
me”) would be correlated with IndSC; in other words,
those who fundamentally construe themselves as indi-
viduals may take a more personal interest in medical de-
cision making. We also supposed that AMO (e.g., “It’s
important to strive for advanced medical care” and “I
want to be treated at a noted hospital”) would show a
correlation with InterSC; that is, having a group-
oriented awareness of medicine could affect the value in-
dividual respondents place on medical treatment that is
based on social norms or expectations.
Participants and measure
The questionnaire was distributed to university students
in the Kansai region of Japan. They were asked to com-
plete the questionnaire after a psychology class in May
2012. The data from Study 2 was part of another ques-
tionnaire survey. Notably, some of the respondents from
Study 2 could have answered the questionnaire in Study
1. To avoid analyzing the same students twice, we made
sure to treat them as separate groups while handing out
the questionnaire. Of the 518 students given the ques-
tionnaire, 335 filled it in completely (200 women and
135 men; mean age = 19.6; SD = 2.9); we excluded any
answer sheets that contained missing data.
Motivation for medical treatment was measured using
the AMI-MeT. To validate the dualistic concepts of the
AMI-MeT subscales, we administered the Self-Construal
Scale (SCS) [40], which is based on the concept of self-
construal [23]. The SCS was translated into Japanese by
Takahashi et al. [41]. Using a 7-point Likert-type scale
(1 = strongly disagree to 7 = strongly agree), participants
indicated their level of agreement with 12 items asses-
sing IndSC (e.g., “I prefer to be direct and forthright
when dealing with people I’ve just met,” “I enjoy being
unique and different from others in many respects”) and
12 statements assessing InterSC (e.g., “It is important for
me to maintain harmony within my group,” “It is im-
portant to me to respect decisions made by the group”).
Analysis 3: correlations between the subscales of the
AMI-MeT and SCS
To demonstrate the convergent and divergent validity of
the subscales of the AMI-MeT with the dualistic
Hatta et al. BMC Medical Informatics and Decision Making  (2016) 16:22 Page 4 of 8
concepts of the self, we calculated the Pearson’s correl-
ation coefficients between the AMI-MeT subscales and
SCS subscales. This statistical analysis was performed
with SPSS 22.0.
Results
Results from analysis 1: multi-group structural equation
modeling
Descriptive statistics and correlation matrixes of the AMI-
MeT items are reported in detail in Additional file 1. The
results of the multi-group SEM with maximum likelihood
estimation supported the two-factor structure of the
AMI-MeT. The configural invariance model fit the data
for both groups (CFI: .911; GFI: .929; AGFI: .886; RMSEA:
.048). After testing the configural invariance model, we
tested the other invariance models according to several
sets of constraints. The chi-square test (χ2/df) and the
chi-square difference test (Δχ2) showed that the weak in-
variance model was the best fit for the data (Table 2), al-
though the items did not follow a normal distribution
(Additional file 1). The fit indices also indicated that the
weak invariance model was the best fit for the data
(Table 2). Accordingly, we regarded the weak invariance
model as the best model, and have displayed the standard-
ized estimations of the model in Fig. 1. In the weak invari-
ance model, the obtained ω for AMO and AMS ranged
from .67–.75 and .72–.79, respectively, indicating high in-
ternal consistency. The results of the SEM and the high
internal consistency reliability coefficients indicate that
the two-factor model of the AMI-MeT was reliable and
that the factor loadings of the AMO and AMS were com-
mon across the three groups.
Result from analysis 2: one-way analysis of variance of
AMI-MeT scores between the three groups
The mean score of the AMI-MeT (ten items) was com-
pared between the three groups. The score of workers
and cancer patients were significantly higher than was
that of students (F(2, 616) = 9.31, P < .01, η2 = .029;
worker vs. student: P < .01; cancer patient vs. student:
P < .01). The difference was also found for the mean
scores of the AMO (five items); in contrast, AMS scores
(five items) did not significantly differ between groups
(Table 3).
Result from analysis 3: correlations between the subscales
of the AMI-MeT and SCS
Before examining the correlations, we calculated the
Cronbach’s alphas of the subscales of both the AMI-
MeT and the SCS, as follows: AMS and AMO, α = .79
and .75, respectively; IndSC and InterSC, α = .69 and .74,
respectively. The correlation analysis revealed that the
AMS scores were more related with the IndSC scores
(r = .25, P < .01) than with the InterSC scores (r = .19,
P < .01), and that the AMO scores were more related
with the InterSC scores (r = .30, P < .01) than with the
IndSC scores (r = .14, P < .05). Because there was a high
correlation between AMS and AMO (r = .64, P < .01), a
partial correlation analysis was also conducted. When we
controlled for AMO in investigating the relationships be-
tween AMS and IndSC and between AMS and InterSC,
we found partial correlations of r = .22 (P < .01) and r = .00
(n.s.), respectively. Furthermore, when we controlled
for AMS in investigating the relationships between
AMO and IndSC and between AMO and InterSC, we
found partial correlations of r = -.03 (n.s.) and r = .24
(P < .01), respectively.
Discussion
We examined the factorial validity and the internal
consistency reliability of the AMI-MeT by confirming
the two-factor model in multiple groups (Analysis 1),
and examined the concurrent validity of the AMI-MeT,
as it exhibited significant differences in the mean score
between groups (Analysis 2). Additionally, we demon-
strated the convergent and divergent validity of the sub-
scales of the AMI-MeT using the SCS, as we believed
that motivation for medical treatment would be theoretic-
ally linked with the concept of self-construal (Analysis 3).
As demonstrated in Analysis 1, the AMI-MeT has a
two-factor structure (AMS and AMO). Notably, as
shown in Analysis 2, the AMO scores of workers and
cancer patients were significantly higher than were those
of students, while the AMS scores did not differ among
Table 2 Test of measurement equivalences for Achievement Motive Index for Medical Treatment
Fit indexes χ2 df p χ2/df Δχ2 Δdf p’ CFI GFI AGFI AIC RMSEA
Configural invariance model 244.051 102 .000 2.393 - - - .911 .929 .886 370.051 .048
Weak invariance model 265.043 118 .000 2.246 20.992 16 .179 .908 .923 .893 359.043 .045
Strong invariance model 301.086 120 .000 2.509 57.035 18 .000 .887 .912 .878 391.086 .049
Complete invariance model 400.484 140 .000 2.861 156.433 38 .000 .837 .888 .868 450.484 .055
Equivalences for AMI-Met were tested in sequence by placing constraints on the parameters (i.e., factor loadings, factor variances/covariance, and error variances).
Configural invariance is the simplest form without any constraints on the parameters. Weak invariance constrains the factor loadings; strong invariance
constrains the factor loadings and factor variances/covariance; and complete invariance constrains the factor loadings, factor variances/covariance, and
error. The difference in the χ2 values (Δχ2) and the degrees of freedom (Δdf) were calculated as follows: Δχ2 = χ2nested model − χ
2
configural invariance model, and
Δdf = dfnested model − dfconfigural invariance model. p’ indicates the significance distributed from Δχ
2 and Δdf [24]
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the groups. We expected both workers and cancer pa-
tients to recognize the need for medical treatment because
they had actually come to the hospital, whereas university
students might not recognize such a need—thus, the items
of the AMO subscale may accurately reflect the value a re-
spondent assigns on the basis of social norms or expecta-
tions, rather than personal interest. Accordingly, the
AMO could be considered to have good concurrent valid-
ity. It must be noted that the concurrent validity of the
AMS could not be discussed in the same manner as that
of the AMO in this research setting, because the items of
the AMS are not as reflective of visiting the hospital as are
the items of the AMO.
Regarding the convergent and divergent validity of the
subscales of the AMI-MeT (Analysis 3), the hypothesized
strong associations (i.e., the correlations between AMS
and IndSC and between AMO and InterSC, which were
r = .25 and .30, respectively) were barely stronger than
were those expected to be low (i.e., the correlations be-
tween AMS and InterSC and between AMO and IndSC,
which were r = .19 and .14, respectively). However, given
that the conceptual similarity between AMS and AMO
could result in their being highly correlated (which was
supported by our results; r = .64, P < .01), we also con-
ducted a partial correlation analysis to eliminate the poten-
tial confounds. As the partial correlation analysis indicated,
there were weak but significant associations between AMS
and IndSC and between AMO and InterSC (.22 and .24,
respectively), and no associations between AMS and
InterSC and between AMO and IndSC (.00 and -.03, re-
spectively). Thus, this partial correlation analysis while
controlling for AMS and AMO supports the convergent
and divergent validity of the subscales of the AMI-MeT.
With regard to the patient group, our interpretations
must be carefully made; if a patient would urgently require
medication and clearly express his or her interest, it would
seem natural for him or her to mark the highest score on
every question of the AMI-MeT. As such, at this point, it
appears difficult to divide patients’ motivation into per-
sonal interest or established value based on social norms
and expectations using the AMI-MeT. Additionally, AMO
and AMS scores showed ceiling effects for cancer patients
as well as stronger correlations in this group. An explan-
ation for these results could be that cancer patients ur-
gently require medication and hence have a high interest
in treatment. As such, this ten-item AMI-MeT would be
useful in the field of medical decision making for detecting
patients with lower levels of motivation, who may require
further assessment and support.
Application of the AMI-MeT in future analyses
To identify how motivation functions in this respect
and investigate the qualities of actual physician–patient
interaction during clinical consultation, we created the
MORE-IC Project [12, 13]. In this study project, we
collected both quantitative and qualitative data, includ-
ing AMI-MeT scores, audio records, and field notes of
participant observations of informed consent consulta-
tions for starting chemotherapy. As the results of the
present study showed, the AMI-MeT can accurately
distinguish patients with high and low motivations, and
provides baseline data on patient motivation for our
research project. In the future, the AMI-MeT will allow
formal comparison of the process of informed consent
Table 3 Scores of the Achievement Motive Index for Medical Treatment in Study 1
Students Workers Cancer patients Multiple
comparisonn = 414 n = 154 n = 51
Mean S.D. Mean S.D. Mean S.D. F p
AMI-MeT 55.35 6.44 56.89 5.94 59.33 10.99 9.31 .000 Sa <Wb, Pc
AMO 26.52 3.94 28.14 3.66 29.70 5.67 19.55 .000 S < W, P
AMS 28.83 3.53 28.75 3.22 29.67 5.83 1.30 .274
aS = Student group
bW =Worker group
























Fig. 1 The standardized values in the hypothesized weak invariance
model. The circles represent the latent factors of AMO and AMS, the
rectangles represent measured indicators (i.e., Q1–Q5 represent AMO,
and Q6–Q10 represent AMS), the lines connecting latent factors to
indicators represent factor loadings, and the curve connecting the two
latent factors represents covariation. The numbers provided are
standardized values for the student group, the worker group (in
parentheses), and the patient group [in brackets]
Hatta et al. BMC Medical Informatics and Decision Making  (2016) 16:22 Page 6 of 8
consultations between patients with high and those
with low motivation.
Limitations
The limitations are as follows. First, the two-factor
model of the AMI-MeT is incomplete. Due to an unbal-
anced sample size, the results of the SEM were biased by
the data from the student group. If each group were
equal in sample size, several fit indexes could be chan-
ged and it is possible that the two-factor model would
not have been proposed. Given that cancer patients
showed higher correlations between AMS and AMO
than did the other groups, the AMI-MeT could have a
one-factor model. A one-factor model would not pre-
cisely contradict our results herein, because our two-
factor model does not specify that the AMO and AMS
subscales were independent. Thus, the factorial validity
of the AMI-MeT remains to be clarified.
Second, although the results of the correlation analysis
demonstrated the convergent and divergent validity of
AMI-MeT subscales with the SCS subscales, the correla-
tions between AMS and IndSC and between AMO and
InterSC must be interpreted cautiously for the following
two reasons. First, the Cronbach’s alphas of the IndSC and
InterSC subscales seemed to be lower (α = .69 and .74, re-
spectively) than in previous studies. Takahashi et al.
(2009) reported Cronbach’s alphas of .48–.58 for the
IndSC subscale and .86–.87 for the InterSC subscale [41];
overall, the inter-item reliabilities of these two subscales
tend to be adequate at best (α = .73–.74 and .69–.70 on
the IndSC and InterSC subscales, respectively [40]). Sec-
ond, there was a conceptual mismatch between the AMO
and InterSC subscales. That is, the items of the AMO sub-
scale did not refer to the relationship with clinical profes-
sionals but to the collective awareness for medical
treatment; in contrast, Markus and Kitayama defined
InterSC according to relationships with others [23]. These
reasons doubtlessly limit the convergent and divergent
validity of AMI-MeT subscales in this research.
Finally, our results cannot generalize to all cancer pa-
tients. We limited our sample to cancer patients who were
diagnosed with breast or lung cancer and who were asked
to answer the AMI-MeT before their clinical consultation
for starting outpatient chemotherapy in a university hos-
pital. Because individuals’ concerns about cancer treat-
ment likely differ depending on their possible treatment
options, disease stage, or social role, further investigation
is required to explore how patients’ interests vary.
Conclusion
We confirmed the validity and reliability of the two-factor
model of the AMI-MeT and checked that the AMI-MeT
could accurately measure motivation for medical treat-
ment among different groups. In the future, when we
investigate how shared decision making proceeds between
Japanese physicians and patients or what occurs in their
conversation process, the AMI-MeT will be useful tool for
detecting patients with high and low motivation.
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